Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price negotiations after early benefit assessment between pharmaceutical companies and the German National Association of Statutory Health Insurance Funds. The analysis was conducted for...

We study the steady upward trend of Health Care Expenditures (HCE) over GDP for a sample of OECD countries between 1970 and 2007. While the US is clearly an outlier, almost all of the additional increase in US HCE happened during the 1978-1990 period. We perform two growth accounting exercises...

The Affordable Care Act (ACA) may be the most important health law statute in American history, yet much of the most prominent legal scholarship examining it has focused on the merits of the court challenges it has faced rather than delving into the details of its priority-setting provisions. In...

A versão em português deste texto está disponível em: "http://ssrn.com/abstract=2441607" http://ssrn.com/abstract=2441607 La versione italiana di questo documento è disponibile all'indirizzo: "http://ssrn.com/abstract=2607031" http://ssrn.com/abstract=2607031La versión en español de este...

Hepatitis C is a major public health concern due to its high rates of infection and mortality. Recent breakthroughs in pharmaceuticals not only have the potential to cure hepatitis C but could also cause large positive health externalities through reduced transmission. The high cost of these...

Policymakers have historically attempted to influence quality in nursing homes through the imposition of minimum staffing standards (MSS) and through the public dissemination of quality on websites like Care Compare. Current Federal MSS require a registered nurse (RN) on duty for at least eight...

The COVID-19 pandemic resulted in an explosion in demand for telemedicine and with it myriad new, untested telemedicine policies. We isolate the impact of a policy which selectively removed cost-sharing for telemedicine services from April-September 2020, estimating changes in telemedicine...

This paper examines the extent to which government programs should monitor for wasteful expenditure when outsourcing to third parties, taking into account the costs and savings associated with monitoring. I use novel administrative data to study the largest Medicare monitoring program aimed at...

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...